Current News
Page 1 of 2

EQT Partners and ADIA is in Talks to Buy Dechra Pharmaceuticals

INFLATED PRICES: Drug Maker Teva Pharmaceuticals Gets Caught up in Alleged Kickbacks

Taro Pharmaceuticals U.S.A. Charged by DOJ in Ongoing Criminal Antitrust Investigation

Blackstone Takes a Strategic Gamble on Alnylam Pharmaceuticals

Ayala Pharmaceuticals Raises Series B Round

Temasek Subscribes to Roughly 3.6% of Bayer AG

SWFI Institutional Investor Forum 2018 – Santa Monica Slider10

Two Sovereign Funds Back Series C in Codiak BioSciences

Malaysian Sovereign Wealth Backs Bay Area Pharma Company
03/02/2016Institutional Investors: Winners and Losers if Trump Wins
02/26/2016Australia’s Future Fund Takes a Page from Alaska

Alaskan SWF Invests in Series B on Anti-Cancer Biotech

Temasek Leads Series C in ASLAN Pharmaceuticals

Sovereign Fund Direct Investing in Healthcare Remains Constant

Middle East Sovereign Fund Boosts Position in Mylan

See Why the Alaska Permanent Fund is Smiling

Temasek and CVC Capital Partners Acquire Majority Stake in Alvogen

REPEAT: Alaska Permanent Fund Takes Stake in Denali Therapeutics

COMPETITION: Sovereign Wealth Funds Spice Up Deal Activity in Asia
